CELLECTAR BIOSCIENCES INC (CLRB) Stock Balance Sheet
NASDAQ:CLRB - Nasdaq - US15117F8077 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 13.91M | 23.29M | 9.56M | 19.87M | 35.70M | |||
| Other Current Assets | 987.50K | 961.70K | 888.20K | 660.00K | 870.00K | |||
| Total Current Assets | 14.89M | 24.25M | 10.45M | 20.53M | 36.57M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.12M | 1.19M | 1.59M | 980.00K | 550.00K | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 29.80K | 29.80K | 29.80K | 80.00K | 80.00K | |||
| Total Non-Current Assets | 1.15M | 1.22M | 1.62M | 1.06M | 630.00K | |||
| TOTAL ASSETS | 16.04M | 25.47M | 12.08M | 21.59M | 37.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 88.20K | 2.23M | 2.37M | 1.33M | 690.00K | |||
| Accounts Payable | 3.87M | 5.44M | 6.87M | 4.20M | 3.30M | |||
| Other Current Liabilities | 2.06M | 1.72M | 3.70M | N/A | N/A | |||
| Total Current Liabilities | 6.02M | 9.39M | 12.94M | 5.53M | 3.99M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 386.20K | 409.60K | 494.00K | 550.00K | 170.00K | |||
| Total Non-Current Liabilities | 386.20K | 409.50K | 494.00K | 550.00K | 170.00K | |||
| TOTAL LIABILITIES | 6.41M | 9.80M | 13.43M | 6.08M | 4.16M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -253.95M | -247.34M | -217.48M | -179.50M | -150.90M | |||
| Additional Paid In Capital | 261.68M | 261.12M | 210.07M | 193.62M | 182.56M | |||
| Common Shares | 1.90M | 1.90M | 6.06M | 1.38M | 1.38M | |||
| Shares Outstanding | 46.08M | 46.08M | 20.74M | 9.39M | 6.11M | |||
| Tangible Book Value per Share | 0.17 | 0.30 | -0.36 | 1.50 | 5.18 | |||
| Total Shareholders' Equity | 9.64M | 15.68M | -1.36M | 15.51M | 33.05M | |||
| TOTAL LIABILITIES AND EQUITY | 16.04M | 25.47M | 12.08M | 21.59M | 37.20M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 2.47 | 2.58 | 0.81 | 3.71 | 9.17 | |||
| Return On Assets (ROA) | -152.99% | -175.01% | -354.19% | -132.47% | -64.84% | |||
| Return On Equity (ROE) | -254.72% | -284.38% | N/A | -184.40% | -72.98% | |||
All data in USD , ROIC based on taxRate of 0.21